{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T01:27:34Z","timestamp":1649122054579},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.trsl.2009.03.001","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T18:24:48Z","timestamp":1238437488000},"page":"272-274","source":"Crossref","is-referenced-by-count":0,"title":["Low-dose aspirin has no impact on systemic level of serine protease inhibitors in healthy volunteers"],"prefix":"10.1016","volume":"153","author":[{"given":"Thomas","family":"Wex","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Treiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Wex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Malfertheiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2009.03.001_bib1","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1080\/00365520802158598","article-title":"Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin\/alpha-1 peptidase inhibitor (alpha1-PI) levels in antral mucosa and peripheral blood","volume":"43","author":"Wex","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.trsl.2009.03.001_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9343(88)80073-1","article-title":"Intravenous administration of alpha-1-proteinase inhibitor in patients of PiZ and PiM phenotype","volume":"84","author":"Moser","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.trsl.2009.03.001_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00003088-199223020-00007","article-title":"Clinical pharmacokinetics of alpha 1-antitrypsin in homozygous PiZ deficient patients","volume":"23","author":"Constans","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.trsl.2009.03.001_bib4","first-page":"163","article-title":"Serum C-reactive protein as a marker for wellness assessment","volume":"36","author":"Kao","year":"2006","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.trsl.2009.03.001_bib5","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.trsl.2009.03.001_bib6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ygyno.2004.10.036","article-title":"Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis","volume":"96","author":"Tsukishiro","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.trsl.2009.03.001_bib7","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/00003246-200005000-00003","article-title":"Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia","volume":"28","author":"Grobmyer","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.trsl.2009.03.001_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1465-9921-9-35","article-title":"SAPALDIA Team. Circulating alpha1-antitrypsin in the general population: determinants and association with lung function","volume":"9","author":"Senn","year":"2008","journal-title":"Respir Res"},{"key":"10.1016\/j.trsl.2009.03.001_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.amjmed.2007.07.025","article-title":"Alpha-1 antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis, and treatment","volume":"121","author":"K\u00f6hnlein","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.trsl.2009.03.001_bib10","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1378\/chest.128.4.2076","article-title":"Alpha1-antitrypsin deficiency in 26-year-old subjects: lung, liver, and protease\/protease inhibitor studies","volume":"128","author":"Piitulainen","year":"2005","journal-title":"Chest"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524409000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524409000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T14:51:13Z","timestamp":1545317473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524409000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1931524409000516"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2009.03.001","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}